Impact of Siderophore Genes on Cefiderocol Susceptibility in Carbapenem Resistant Hypervirulent Klebsiella Pneumoniae

Sohag University

Status: Not yet enrolling

Conditions: Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae Infection

Treatments: Diagnostic Test: Cefiderocol susceptibility testing

Study type: Observational

Funder types: Other

Identifiers

NCT07475429

Soh-Med--25--12-3MS

Details and patient eligibility

About

1. Sample: Clinical specimens (blood, urine, sputum, wound swabs) will be collected aseptically and transported to the microbiology laboratory for analysis.

2. Culture: Specimens will be inoculated on MacConkey agar and incubated at 35-37°C for 18-24 hours. Colonies with typical K. pneumoniae morphology (mucoid, lactose-fermenting) will be selected for further testing

3. Identification of isolates will be done by:

   Colony morphology, Gram staining, and conventional biochemical tests (eg, indole, citrate utilization, urease, Voges-Proskauer) .

4. Antimicrobial susceptibility testing of the isolates :

   Antimicrobial susceptibility testing was performed and interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines, M100 document (latest edition)."

5. MIC determination for cifederecol using E-test .

6. Phenotypic Detection of hvKP:

   1. String Test: A viscous string ≥5 mm formed by stretching a single colony indicates hypermucoviscosity .
   2. Capsule Staining: to visualize large capsules .
   3. Siderophore Production: Assessed on chrome azurol S (CAS) agar to detect iron-chelating activity.

7. Detection of siderophore genes by Simple qualitative PCR .

Full description

Klebsiella pneumoniae ( K.pneumoniae ) is a Gram-negative, encapsulated, non-motile bacterium of the Enterobacteriaceae family and a major pathogen responsible for a broad spectrum of healthcare- and community-acquired infections, including pneumonia, urinary tract infections, bloodstream infections, and pyogenic liver abscesses

1. Sample: Clinical specimens (blood, urine, sputum, wound swabs) will be collected aseptically and transported to the microbiology laboratory for analysis.

2. Culture: Specimens will be inoculated on MacConkey agar and incubated at 35-37°C for 18-24 hours. Colonies with typical K. pneumoniae morphology (mucoid, lactose-fermenting) will be selected for further testing

3. Identification of isolates will be done by:

   Colony morphology, Gram staining, and conventional biochemical tests (eg, indole, citrate utilization, urease, Voges-Proskauer) .

4. Antimicrobial susceptibility testing of the isolates :

   Antimicrobial susceptibility testing was performed and interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines, M100 document (latest edition)."

5. MIC determination for cifederecol using E-test .

6. Phenotypic Detection of hvKP:

   1. String Test: A viscous string ≥5 mm formed by stretching a single colony indicates hypermucoviscosity .
   2. Capsule Staining: to visualize large capsules .
   3. Siderophore Production: Assessed on chrome azurol S (CAS) agar to detect iron-chelating activity.

7. Detection of siderophore genes by Simple qualitative PCR .

Enrollment: 100 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

- 1. Patients with hypervirulant K. pneumoniae infection from various clinical specimens (blood, urine, sputum, wound swabs, etc.) Confirmed by culture and initial laboratory testing .

2. Age and sex range: any age and any sex.

Exclusion criteria

- Patients who received antibiotic treatment in the 48 hours prior to sample collection.

2. Patients with incomplete clinical data or inadequate samples.

Trial design

100 participants in 2 patient groups

• Cefiderocol susceptible CR-hvKP isolates

Description:

Clinical carbapenem-resistant hypervirulent Klebsiella pneumoniae isolates that test positive for siderophore genes. These isolates will be evaluated for susceptibility to cefiderocol using standard antimicrobial susceptibility testing methods.

Treatment:

Diagnostic Test: Cefiderocol susceptibility testing

Cefiderocol resistant CR-hvKP isolates

Description:

Clinical isolates of carbapenem-resistant hypervirulent Klebsiella pneumoniae collected from clinical samples. Isolates will be tested for the presence of siderophore genes and their susceptibility to cefiderocol using standard antimicrobial susceptibility testing methods.

Treatment:

Diagnostic Test: Cefiderocol susceptibility testing